Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page update introduces Revision: v3.6.5 and removes several history-related sections from the study record view, altering how past changes and results are accessed within the history page.SummaryDifference11%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedA new site revision entry, v3.6.4, has been added to the Study Record History, replacing the previous revision v3.6.3.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history now shows a new revision (v3.6.3) replacing the previous v3.6.2. This indicates a minor platform update rather than a content change on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision label v3.6.2 was added and the previous v3.6.0 label removed, indicating a backend/UI update to the history display rather than changes to the trial data.SummaryDifference0.1%

- Check64 days agoChange DetectedThe study record now shows that recruitment is closed (no longer looking for participants) and includes a new revision tag v3.6.0 in the history.SummaryDifference0.5%

- Check72 days agoChange DetectedThe page history now includes a new revision label v3.5.5, replacing the previous v3.5.4, indicating the study record has been updated.SummaryDifference0.1%

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.